指南与共识特殊人群用药药物不良反应与药物警戒

妊娠药物警戒研究中核心数据元素建议:IMI ConcePTION项目

Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION Project.
指南 / 共识 · Drug Saf · 2023-03-28

文章介绍IMI ConcePTION项目制定的妊娠药物警戒原始数据收集核心数据元素参考框架。该框架由多学科专家通过范围综述和讨论形成,包含98个数据元素,分14张表,公开于ENTIS网站,旨在标准化数据收集、促进数据协调与证据合成。

要点

  • 核心数据元素框架含98个数据元素,分14张表,公开可获取。
  • 框架由多学科专家通过范围综述和讨论制定,用于标准化妊娠药物警戒原始数据收集。
  • 标准化数据收集有望提高妊娠用药安全证据合成速度与质量。

核心结论

  • 该核心数据元素参考框架可用于标准化妊娠药物警戒原始数据收集,改善数据协调与证据合成能力。

研究设计与样本

  • 由IMI ConcePTION项目中药物警戒、药物流行病学、医学统计等多学科专家制定。
  • 通过范围综述现有妊娠药物警戒数据集的数据收集系统,并经广泛讨论形成框架。

主要发现

  • 最终核心数据元素列表包含98个数据元素, arranged into 14张相关字段表。
  • 数据元素公开于欧洲致畸信息服务机构网络(ENTIS)网站。

关键数值与推荐

  • 核心数据元素共98个,分14张表。

临床怎么用

  • 在妊娠药物警戒原始数据收集研究中采用该核心数据元素框架,以促进数据标准化与证据合成。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION AND OBJECTIVE: The risks and benefits of medication use in pregnancy are typically established through post-marketing observational studies. As there is currently no standardised or systematic approach to the post-marketing assessment of medication safety in pregnancy, data generated through pregnancy pharmacovigilance (PregPV) research can be heterogenous and difficult to interpret. The aim of this article is to describe the development of a reference framework of core data elements (CDEs) for collection in primary source PregPV studies that can be used to standardise data collection procedures and, thereby, improve data harmonisation and evidence synthesis capabilities. METHODS: This CDE reference framework was developed within the Innovative Medicines Initiative (IMI) ConcePTION project by experts in pharmacovigilance, pharmacoepidemiology, medical statistics, risk-benefit communication, clinical teratology, reproductive toxicology, genetics, obstetrics, paediatrics, and child psychology. The framework was produced through a scoping review of data collection systems used by established PregPV datasets, followed by extensive discussion and debate around the value, definition, and derivation of each data item identified from these systems. RESULTS: The finalised listing of CDEs comprises 98 individual data elements, arranged into 14 tables of related fields. These data elements are openly available on the European Network of Teratology Information Services (ENTIS) website ( http://www.entis-org.eu/cde ). DISCUSSION: With this set of recommendations, we aim to standardise PregPV primary source data collection processes to improve the speed at which high-quality evidence-based statements can be provided about the safety of medication use in pregnancy.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Richardson JL, Moore A, Bromley RL, et al. Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION Project. Drug Saf. 2023. PMID: 36976447. doi:10.1007/s40264-023-01291-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。